Water Island Capital’s Tourmaline Bio TRML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-50,968
Closed -$2.44M 128
2025
Q3
$2.44M Buy
+50,968
New +$1.41M 0.31% 56

Water Island Capital's TRML Position: Q4 2025 in Review

Water Island Capital sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 50,968 shares — an estimated $2.44M sold.

Water Island Capital first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $2.44M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Water Island Capital reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Water Island Capital sold 50,968 Tourmaline Bio shares in Q4 2025, an estimated $2.44M.
  • Water Island Capital first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
  • Water Island Capital's Tourmaline Bio position peaked at $2.44M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Water Island Capital's 13F filing for Q4 2025, filed 17 Feb 2026.